Prof. Susann Weihrauch-Blüher (MS, PhD) is Senior Consultant for Pediatric Endocrinology and Diabetology at the University Medicine of Halle, Germany. Her clinical emphasis includes all aspects of Pediatric Endocrinology; her research focus comprises obesity, Metabolic Syndrome/prediabetes and T2D in childhood and adolescence with prevention strategies, treatment options and comorbidities. She is Co-Investigator of the EU-funded project PAS GRAS (HORIZON HLTH-2022-STAYHLTH-01-05: De-Risking Metabolic, Environmental and Behavioral Determinants of Obesity in Children, Adolescents, and Young Adults; 2023-2028) and also participated in the EU-funded project PreSTART (EU Tender/Public Health; 2014-2019): Prevention of Type2 Diabetes in adolescents aged 12 – 14 years). Prof. Weihrauch-Blüher received her clinical and scientific training at the University Medicine of Leipzig, Germany; the East General Hospital of Toronoto, Canada; the Alfred Hospital in Melbourne, Australia, as well as Beth Isreal Deaconess Medical Center, Harvard University; Boston/US. Since 2024, she is Vice President of the German Obesity Society (DAG). Between 2019 and 2024, she was the speaker oft he Working Group of Childhood Obesity (AGA) of the DAG.

Amalia Gastaldelli is Director of Research at the Institute of Clinical Physiology of National Research Council in Pisa, Italy, where she leads the Cardiometabolic Risk Group. She is also Adjunct Professor at UT Health San Antonio, TX, USA and at the Sant’Anna School in Pisa. Her research focuses on the pathophysiology of metabolic diseases, particularly MASLD, obesity, and type 2 diabetes, with emphasis on metabolic fluxes and hormone action. She is President of the European MASLD Study Group (EASD) and of EGIR-European Group for Insulin Resistance affiliated to EASD. She has served on international committees for clinical guidelines on MASLD/NAFLD and diabetes (EASL–EASD–EASO; IDF).